By analyzing the genome-wide sequencing data of human glioma samples provided by TCGA, we found that the expression levels of HTR5A was decreased in glioblastoma patients compared to low-grade gliomas including oligodendroglioma, oligoastrocytoma, and astrocytoma (Fig. 1A). This evidence concerns the gene HTR5A and oligodendroglioma.